Diaphragmatic excursion correlates with exercise capacity and dynamic hyperinflation in COPD patients

膈肌运动幅度与慢性阻塞性肺疾病患者的运动能力和动态肺过度充气相关

阅读:2

Abstract

BACKGROUND: Although the pathophysiological mechanisms involved in the development of dyspnoea and poor exercise tolerance in patients with COPD are complex, dynamic lung hyperinflation (DLH) plays a central role. Diaphragmatic excursions can be measured by ultrasonography (US) with high intra- and interobserver reliability. The objective of this study was to evaluate the effect of diaphragmatic excursions as assessed by US on exercise tolerance and DLH in patients with COPD. METHODS: Patients with COPD (n=20) and age-matched control subjects (n=20) underwent US, which was used to determine the maximum level of diaphragmatic excursion (DE(max)). Ventilation parameters, including the change in inspiratory capacity (ΔIC), were measured in the subjects during cardiopulmonary exercise testing (CPET). We examined the correlations between DE(max) and the ventilation parameters. RESULTS: The DE(max) of patients with COPD was significantly lower than that of the controls (45.0±12.8 mm versus 64.6±6.3 mm, respectively; p<0.01). The perception of peak dyspnoea (Borg scale) was significantly negatively correlated with DE(max) in patients with COPD. During CPET, oxygen uptake/weight (V'(O(2)) /W) and minute ventilation (V'(E)) were significantly positively correlated with DE(max), while V'(E)/V'(O(2)) and V'(E)/carbon dioxide output (V'(CO(2)) ) were significantly negatively correlated with DE(max) in patients with COPD. DE(max) was also significantly positively correlated with ΔIC, reflecting DLH, and with V'(O(2)) /W, reflecting exercise capacity. CONCLUSION: Reduced mobility of the diaphragm was related to decreased exercise capacity and increased dyspnoea due to dynamic lung hyperinflation in COPD patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。